T1	HMM 449 474	progression-free survival
T2	HMM 847 872	progression-free survival
T3	HMM 1041 1049	survival
T4	HMM 1187 1317	account disease extent, maintenance therapy, Karnofsky performance status (PS), and absolute dose-intensity (ADI) of anthracycline
T5	HMM 1342 1378	limited disease (LD) and maintenance
T6	HMM 1431 1440	survival.
